Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

University Hospital Graz, Department of Neuro-Ophthalmology, Graz, Austria

In this page

How to contact the center

Affiliated

HCP Center

The Styrian Hospital Corporation (KAGes) is an organisation which manages 19 hospitals in Styria on 22 locations, with 1 university clinic, 1 center hospital, 17 standard hospitals and 1 nursing home. The KAGes is to 100% in the property of the Styrian government. It is the biggest employer in Styria, with about 17.000 employees and a financial volume of about 1.3 billion Euro. With more the 6.000 beds, KAGes is not only the main provider of hospital medical services in Styria, every hospital is also an economic factor in its region. KAGes operates under the Austrian Health Structure Plan, medical services are coordinated and demand-oriented.

Picture : Ernstl

Contact

University Hospital Graz, Department of Neuro-Ophthalmology, Graz, Austria

Auenbruggerplatz 4
8036 Graz
Austria

Team

Pr Andreas Wedrich

Representative

Austria

See more

Dr Haleh Aminfar

Austria

Neuro-Ophthalmology Rare Diseases (WG2)
See more

Pr Jutta Berglöff

Austria

Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), Neuro-Ophthalmology Rare Diseases (WG2), Research (TWG8)
See more

Dr Thomas Georgi

Austria

CPMS & Digital Medecine (TWG10), National Integration (TWG9), Neuro-Ophthalmology Rare Diseases (WG2), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
See more

Dr Manuel Großpötzl

Austria

Neuro-Ophthalmology Rare Diseases (WG2), Research (TWG8)
See more

Dr Mona Schneider

Austria

CPMS & Digital Medecine (TWG10), Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Neuro-Ophthalmology Rare Diseases (WG2), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
See more

Dr Sanja Strini

Austria

Neuro-Ophthalmology Rare Diseases (WG2)
See more

Dr Katharina Valentin

Austria

National Integration (TWG9), Neuro-Ophthalmology Rare Diseases (WG2), Research (TWG8)
See more

Clinical trials

NCT05537220 - Active, Not recruiting

NAC Attack, A Phase III, Multicenter, Randomized, Parallel, Double Masked, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral N-Acetylcysteine in Patients With Retinitis Pigmentosa

Interventional
See the trial
voir la fiche
NCT04435366 - Completed

A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Interventional
See the trial
voir la fiche

NCT04423718 - Active, Not recruiting

Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients With Neovascular Age-Related Macular Degeneration

Interventional
See the trial
voir la fiche
NCT05384249 - Recruiting, Active

A Phase 2b Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Non-infectious, Intermediate-, Posterior- or Pan-uveitis

Interventional
See the trial
voir la fiche
NCT05642312 - Recruiting, Active

A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Vamikibart Administered Intravitreally in Patients With Uveitic Macular Edema

Interventional
See the trial
voir la fiche
NCT06007690 - Recruiting, Active

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

Interventional
See the trial
voir la fiche